Journal of Pharmacology and Experimental Therapeutics: 267 (2)

November 01, 1993; Volume 267,Issue 2

You have access
Angiotensin II-induced vasopressin release is mediated through alpha-1 adrenoceptors and angiotensin II AT1 receptors in the supraoptic nucleus.
F Qadri, J Culman, A Veltmar, K Maas, W Rascher and T Unger

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 567-574;
You have access
Mechanism of flecainide's rate-dependent actions on action potential duration in canine atrial tissue.
Z Wang, B Fermini and S Nattel

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 575-581;
You have access
3-Deazaadenosine: a therapeutic strategy for myasthenia gravis by decreasing the endocytosis of acetylcholine receptors.
R W Kuncl, D B Drachman, R Adams and M Lehar

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 582-589;
You have access
Characterization of the tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitors.
S Giuliani, R Patacchini, G Barbanti, D Turini, P Rovero, L Quartara, A Giachetti and C A Maggi

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 590-595;
You have access
Bronchopulmonary actions of 1-(1,2,3,4-tetrahydro-1-naphthylenyl)-1H-imidazole, nitric acid salt (LY150310), a substituted imidazole, in the guinea pig.
P W Stengel, R D Dillard, H L Cho, D W Snyder, S M Spaethe, P A Pechous, R L Obenchain, S L Cockerham and S A Silbaugh

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 596-603;
You have access
Aminopyridine block of potassium channels in mouse neuroblastoma cells.
J K Hirsh and F N Quandt

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 604-611;
You have access
Calcium channel blockers inhibit hydrogen peroxide-induced proliferation of cultured rat mesangial cells.
I Duque, M Rodriguez Puyol, P Ruiz, M Gonzalez-Rubio, M L Diéz Marques and D Rodriguez Puyol

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 612-616;
You have access
Tamoxifen and vanadate synergize in causing accumulation of polyphosphoinositides in GH4C1 membranes.
Z Y Friedman

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 617-623;
You have access
Precipitated withdrawal by pentazocine in methadone-maintained volunteers.
E C Strain, K L Preston, I A Liebson and G E Bigelow

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 624-634;
You have access
Delta 9-tetrahydrocannabinol injection induces cytokine-mediated mortality of mice infected with Legionella pneumophila.
T W Klein, C Newton, R Widen and H Friedman

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 635-640;
You have access
EXP063, a nonpeptide angiotensin II and beta adrenergic receptor antagonist.
P C Wong, J V Duncia, A T Chiu, R E Olson, D H Rominger, S W Tam and P B Timmermans

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 641-647;
You have access
RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
L B Katz, E C Giardino, J J Salata, J B Moore and R Falotico

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 648-656;
You have access
Angiotensin II receptor blockade improves renal function in rats with reduced renal mass.
D M Pollock, B J Divish, J S Polakowski and T J Opgenorth

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 657-663;
You have access
NPC 15669 reduces mortality associated with sepsis in rats.
L Noronha-Blob, V C Lowe, L Otterbein, L Steranka and R M Burch

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 664-669;
You have access
Role of calcium in plasma protein binding and renal handling of alendronate in hypo- and hypercalcemic rats.
J H Lin, I W Chen, F A deLuna and M Hichens

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 670-675;
You have access
Renovascular actions of angiotensin II in the isolated kidney of the rat: relationship to lipoxygenases.
C P Bell-Quilley, Y S Lin, S D Hilchey, E D Drugge and J C McGiff

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 676-682;
You have access
A selective agonist of endothelin type B receptor, IRL 1620, stimulates cyclic GMP increase via nitric oxide formation in rat aorta.
Y Fujitani, H Ueda, T Okada, Y Urade and H Karaki

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 683-689;
You have access
Passage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood-brain barrier.
W A Banks, A J Kastin, G Komaki and A Arimura

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 690-696;
You have access
Enrichment for metallothionein does not confer resistance to cisplatin in transfected NIH/3T3 cells.
K A Morton, B J Jones, M H Sohn, F L Datz and R E Lynch

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 697-702;
You have access
Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids.
I Szabo, M Rojavin, J L Bussiere, T K Eisenstein, M W Adler and T J Rogers

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 703-706;
You have access
Differential regulation of neuropeptide Y systems in limbic structures of the rat.
L P Midgley, L G Bush, J W Gibb and G R Hanson

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 707-713;
You have access
Facilitated dissociation of albumin-fatty acid complexes by rat hepatocytes.
F J Burczynski, J B Moran and Z S Cai

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 714-719;
You have access
Chelation of zinc antagonizes the neuromuscular blocking properties of the seven serotypes of botulinum neurotoxin as well as tetanus toxin.
L L Simpson, J A Coffield and N Bakry

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 720-727;
You have access
Competitive inhibition by capsazepine of [3H]resiniferatoxin binding to central (spinal cord and dorsal root ganglia) and peripheral (urinary bladder and airways) vanilloid (capsaicin) receptors in the rat.
A Szallasi, C Goso, P M Blumberg and S Manzini

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 728-733;
You have access
Divergent pharmacologic activities of PD 132301-2 and CL 277,082, urea inhibitors of acyl-CoA:cholesterol acyltransferase.
B R Krause, A Black, R Bousley, A Essenburg, J Cornicelli, A Holmes, R Homan, K Kieft, C Sekerke and M K Shaw-Hes

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 734-743;
You have access
Insulin is a superior antidote for cardiovascular toxicity induced by verapamil in the anesthetized canine.
J A Kline, C A Tomaszewski, J D Schroeder and R M Raymond

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 744-750;
You have access
Transport of 2,4,5-trichlorophenoxyacetic acid across the blood-cerebrospinal fluid barrier of the rabbit.
C S Kim and J B Pritchard

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 751-757;
You have access
Mechanism-based inactivation of cytochrome P450 1A1 by N-aralkyl-1-aminobenzotriazoles in guinea pig kidney in vivo and in vitro: minimal effects on metabolism of arachidonic acid by renal P450-dependent monooxygenases.
L C Knickle, C D Webb, A A House and J R Bend

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 758-764;
You have access
Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
S Rosenzweig-Lipson and J Bergman

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 765-775;
You have access
Effects of nicotine on neocortical electrical activity in rats.
P Riekkinen, M Riekkinen and J Sirviö

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 776-784;
You have access
Cellular characterization of the pharmacological selectivity and tachyphylactic properties of denopamine for the human beta adrenergic receptors.
T Suzuki, F Nantel, H Bonin, M Valiquette and M Bouvier

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 785-790;
You have access
Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
R K Zalups

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 791-800;
You have access
Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices.
S Jin, B Johansson and B B Fredholm

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 801-808;
You have access
Prevention of experimental carotid artery thrombosis by applaggin.
W E Rote, D X Mu, R A Roncinske, A L Frelinger and B R Lucchesi

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 809-814;
You have access
Types A and B monoamine oxidase contribute to the metabolism of norepinephrine in perfused lungs of rats.
N N Westwood and L J Bryan-Lluka

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 815-821;
You have access
Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine.
M Ogidigben, T C Chu and D E Potter

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 822-827;
You have access
Differential attenuation of the responses to adenosine and methoxamine in isolated rabbit aorta.
H L Wiener and G P Thalody

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 828-837;
You have access
Caffeine withdrawal: apparent heterologous sensitization to adenosine and prostacyclin actions in human platelets.
S Paul, B Kurunwune and I Biaggioni

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 838-843;
You have access
Anticonvulsant doses of 2-chloro-N6-cyclopentyladenosine, an adenosine A1 receptor agonist, reduce GABAergic transmission in different areas of the mouse brain.
A Concas, G Santoro, M P Mascia, E Maciocco, L Dazzi, E Ongini and G Biggio

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 844-851;
You have access
A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86.
K J Chang, G C Rigdon, J L Howard and R W McNutt

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 852-857;
You have access
Antinociceptive actions of BW373U86 in the mouse.
K D Wild, J McCormick, E J Bilsky, T Vanderah, R W McNutt, K J Chang and F Porreca

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 858-865;
You have access
Discriminative stimulus effects of BW373U86: a nonpeptide ligand with selectivity for delta opioid receptors.
S D Comer, R W McNutt, K J Chang, B R De Costa, H I Mosberg and J H Woods

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 866-874;
You have access
A novel delta opioid agonist, BW373U86, in squirrel monkeys responding under a schedule of shock titration.
L A Dykstra, G M Schoenbaum, J Yarbrough, R McNutt and K J Chang

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 875-882;
You have access
A nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat.
P H Lee, R W McNutt and K J Chang

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 883-887;
You have access
Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice.
S D Comer, E M Hoenicke, A I Sable, R W McNutt, K J Chang, B R De Costa, H I Mosberg and J H Woods

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 888-895;
You have access
Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine.
S S Negus, T F Burke, F Medzihradsky and J H Woods

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 896-903;
You have access
Effects of naftidrofuryl on hypoxia-induced activation and mortality of human endothelial cells.
C Michiels, T Arnould, D Janssens, I Alexandre, A Houbion and J Remacle

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 904-911;
You have access
Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine.
D Jackson, E D Abercrombie and M J Zigmond

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 912-918;
You have access
Insulin-like growth factor-I ameliorates transient ischemia-induced acute renal failure in rats.
S Noguchi, Y Kashihara, Y Ikegami, K Morimoto, M Miyamoto and K Nakao

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 919-926;
You have access
Enhanced expression of rat hepatic CYP2B1/2B2 and 2E1 by pyridine: differential induction kinetics and molecular basis of expression.
H Kim, D Putt, S Reddy, P F Hollenberg and R F Novak

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 927-936;
You have access
A study of the dose dependency of a glycine receptor antagonist in focal ischemia.
J Chen, S Graham, F Moroni and R Simon

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 937-941;
You have access
Permeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy.
M A Hurni, A B Noach, M C Blom-Roosemalen, A G de Boer, J F Nagelkerke and D D Breimer

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 942-950;
You have access
Microvascular substance P binding to normal and inflamed rat and human synovium.
D A Walsh, M Salmon, P I Mapp, J Wharton, N Garrett, D R Blake and J M Polak

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 951-960;
You have access
[3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus.
D W Bonhaus, D N Loury, L B Jakeman, Z To, A DeSouza, R M Eglen and E H Wong

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 961-970;
You have access
Autoradiographic distribution of [14C]tetrahydrobiopterin and its developmental change in mice.
M Hoshiga, K Hatakeyama, M Watanabe, M Shimada and H Kagamiyama

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 971-978;
You have access
Role of the complement system in antigen-induced bronchoconstriction and changes in blood pressure in the guinea pig.
J F Regal, D G Fraser and C A Toth

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 979-988;
You have access
Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate.
D B Vinh and R S McIvor

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 989-996;
You have access
Correlation between insulin receptor occupancy and tyrosine kinase activity at low insulin concentrations and effect of major histocompatibility complex class I-derived peptide.
J Stagsted, T Hansen, R A Roth, A Goldstein and L Olsson

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 997-1001;
You have access
Serotonin-induced muscle contraction in rat stomach fundus is mediated by a G alpha z-like guanine nucleotide binding protein.
H Y Wang, K Eberle-Wang, K J Simansky and E Friedman

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 1002-1011;
You have access
Identification of CYP2C23 expressed in rat kidney as an arachidonic acid epoxygenase.
S Imaoka, P J Wedlund, H Ogawa, S Kimura, F J Gonzalez and H Y Kim

Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 1012-1016;

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals